Concepedia

Paul Beswick

PB

32

Publications

1.4K

Citations

23

H-Index

1984

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Bicycle Therapeutics (United Kingdom)

University of Sussex

University of Hertfordshire

University of Cambridge

Paul Beswick is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1984–2025

32

Publications

32

Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors

Oliver N. F. King, Xuan Shirley Li, Masaaki Sakurai et al. · PLoS ONE · 2010 · 222 citations · Full text

Chelation‐Controlled Intermolecular Hydroacylation: Direct Addition of Alkyl Aldehydes to Functionalized Alkenes

Michael C. Willis, Steven J. McNally, Paul Beswick · Angewandte Chemie International Edition · 2003 · 133 citations

, , +11

Novel 1, 2, 4-oxadiazoles as potent and selective histamine H3 receptor antagonists

J. W. CLITHEROW, Paul Beswick, W Irving et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 106 citations

, , +6

Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer

Gemma Mudd, Heather S. Scott, Liuhong Chen et al. · Journal of Medicinal Chemistry · 2022 · 80 citations · Full text

, , +17

Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor

Muna Abdi, Paul Beswick, Andy Billinton et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 70 citations · Full text

, , +10

Rows per page

1–5 of 32